Summary
TAmiRNA aims to commercialize an in-vitro diagnostic test that is intended to predict fracture-risk in case of osteoporosis.Osteoporosis is a chronic skeletal disease characterized by systemic loss of bone strength and consequently high incidence of bone fractures...
More information & hyperlinks
| Web resources: | http://www.tamirna.com/partners-investors.html |